BHC
NYSE · Pharmaceuticals
Bausch Health Cos Inc
$5.67
+0.02 (+0.35%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-16.74%
YTD
-21.36%
Open$5.68
Previous Close$5.65
Day High$5.73
Day Low$5.60
52W High$11.08
52W Low$6.10
Volume—
Avg Volume503.8K
Market Cap2.95B
P/E Ratio—
EPS$-2.96
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$6.64
Below
SMA 200
$6.36
Below
RSI (14)
60
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
8 analysts
Price Target
+1,730.3% upside
Current
$5.67
$5.67
Target
$103.78
$103.78
$65.08
$103.78 avg
$115.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.63B | 12.61B | 415.01M |
| Net Income | 208.43M | 173.52M | 120.28M |
| Profit Margin | 1.5% | 1.5% | 29.0% |
| EBITDA | 3.95B | 3.47B | 156.90M |
| Free Cash Flow | — | — | 115.51M |
| Rev Growth | +8.1% | +8.1% | +10.0% |
| Debt/Equity | 44.72 | 44.72 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |